BioNTech’s oncology vaccine trial sees all patients living kidney cancer-free
Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping cancer.
Experimental vaccine seems to battle advanced kidney cancers
A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, researchers report.
Cancer vaccine prevents recurrence of advanced kidney cancer in small trial
After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to an experimental, personalized cancer vaccine, researchers reported Feb. 5.
'Exciting' cancer vaccine offers hope for patients
Lesley Jenkins had surgery to remove a tumour that was discovered following a routine bowel test.
Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the vaccine candidate appeared to be safe and produced a clear immune response in all nine patients at high risk for recurrences of their cancer.
New Vaccine Shows Promise For Kidney Cancer
A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer three years after the pioneering treatment.
Personalized cancer vaccine shows potential in kidney cancer
In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.
Kidney Cancer Vaccine Shows Promise in Early Trial
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated robust immune response, according to findings of a new study led by HMS researchers at Dana-Farber Cancer Institute.
World Cancer Day: How AI can help in developing personalised cancer vaccines
The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting large-scale clinical trials for potential vaccine candidates remains a significant challenge,
Personalized vaccines halt kidney cancer after encouraging phase 1 trial
In a nutshell Researchers developed personalized cancer vaccines for nine high-risk kidney cancer patients, with all participants remaining cancer-free after nearly three years of follow-up – a significant advancement for a cancer type that traditionally has limited treatment options.
Targeted Oncology1d
No RCC Recurrence in Patients Treated With Adjuvant Neoantigen Vaccine
A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...
Legal experts say RFK Jr.'s move to give financial interest in vaccine lawsuits to family is 'not unusual'
Amid scrutiny over Robert F. Kennedy Jr.'s pledge to divest his financial stake in vaccine lawsuits to his family, legal ...
The American Journal of Managed Care1d
Promising Cancer Vaccine Boosts Hope for Stage III and IV Kidney Cancer
All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.
Medscape10h
Personalized Neoantigen Vaccine Shows Promise in High-Risk Renal Cell Carcinoma
Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...
500 underprivileged girls in Bengaluru receive free HPV vaccines to prevent cervical cancer: Report
In a bid to tackle cervical cancer, one of the leading causes of cancer-related deaths among women, 500 adolescent girls from ...
New cancer vaccine to beat disease and stop it coming back given in Wales
Clinical trial using the same technology as Covid-19 vaccines is designed to fight colorectal cancer and prevent it from ...
Wales' papers: Emergency room war zone and cancer vaccine hope
A review of the front page stories from the daily and weekly newspapers in Wales.
Hosted on MSN2d
MHRA seeks input on new regulatory guidance for cancer vaccines
The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.